These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6215640)

  • 1. Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome.
    Bax ND; Boulton AJ; Woods HF; Green AR
    Postgrad Med J; 1982 Aug; 58(682):493-5. PubMed ID: 6215640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parachlorophenylalanine and ultrastructure in the carcinoid syndrome].
    Rapado A; Oliva H; Traba ML; Díaz Recasens J; Ríuz F; Pérez-Corral F; Farré J; De la Barreda P
    Rev Clin Esp; 1974 Jan; 132(1):11-20. PubMed ID: 4276185
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic acidosis in patients with the carcinoid syndrome: treatment with parachlorophenylalanine.
    Feldman JM
    J Surg Oncol; 1982 Apr; 19(4):219-23. PubMed ID: 6176809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enzyme activity (monoamine oxidase, histaminase, kallikreinogen) in carcinoids treated with parachlorophenylalanine].
    Fanciullacci M; Curradi C; Di Lollo F; Sicuteri F
    Boll Soc Ital Biol Sper; 1975 Sep; 51(17):1025-30. PubMed ID: 130150
    [No Abstract]   [Full Text] [Related]  

  • 5. [The carcinoid syndrome. A case description with special reference to its therapeutic aspects].
    Häussinger D; Koch HK; Köttgen E; Fröhlich J; Gerok W
    Med Welt; 1982 Aug; 33(34):1155-9. PubMed ID: 6215550
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary-gonadal function in the carcinoid syndrome: effect of parachlorophynylalanine therapy.
    Feldman JM; Plonk JW
    Horm Metab Res; 1977 Mar; 9(2):156-60. PubMed ID: 140843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exogenous psychosis in a patient with carcinoid syndrome following treatment with p-chlorophenylalanine (PCPA)].
    Gruner W
    Psychiatr Clin (Basel); 1975; 8(5):266-76. PubMed ID: 131950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal and metabolic function in patients with the carcinoid syndrome.
    Feldman JM; Plonk JW
    Am J Med Sci; 1977; 273(1):43-54. PubMed ID: 192079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological and therapeutic studies (p-chlorphenylalanin) on carcinoid syndrome in 11 cases].
    von Studnitz W; Waldenström J
    Klin Wochenschr; 1971 Jul; 49(13):748-55. PubMed ID: 4254559
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant carcinoid syndrome: two case reports.
    Spann JL; Van Wormer D; Sandlin ME
    J Surg Oncol; 1980; 15(2):187-94. PubMed ID: 6448327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoid myopathy and treatment with cyproheptadine (Periactin).
    Berry EM; Maunder C; Wilson M
    Gut; 1974 Jan; 15(1):34-8. PubMed ID: 4274414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma amino acids in patients with the carcinoid syndrome.
    Feldman JM; Plonk JW; Admiraal J; Sidbury JB
    Cancer; 1976 Nov; 38(5):2127-31. PubMed ID: 136295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothermia in a patient with carcinoid syndrome during treatment with parachlorophenylalanine.
    Vaidya AB; Levine RJ
    N Engl J Med; 1971 Feb; 284(5):255-7. PubMed ID: 5539348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of carcinoid and the carcinoid syndrome].
    Rasenack U; Caspary W
    Dtsch Med Wochenschr; 1983 Apr; 108(17):671-3. PubMed ID: 6188602
    [No Abstract]   [Full Text] [Related]  

  • 15. Parachlorophenylalanine treatment in carcinoid syndrome.
    Shani M; Sheba C
    Br Med J; 1970 Dec; 4(5738):784-5. PubMed ID: 5497409
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical implications of unnatural amino acids and amines.
    Sjoerdsma A
    Fed Proc; 1971; 30(3):908-11. PubMed ID: 4324977
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropharmacological therapy of carcinoid syndrome.
    Lechin F; van der Dijs B
    Neuroendocrinology; 2005; 81(3):137-8. PubMed ID: 15976511
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose metabolism and insulin secretion in the carcinoid syndrome.
    Feldman JM; Marecek RL; Quickel KE; Lebovitz HE
    J Clin Endocrinol Metab; 1972 Aug; 35(2):307-11. PubMed ID: 4262845
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carcinoid syndrome (apropos of 1 case). II. Biologic study and therapeutic note].
    Dreux C; Ingrand J
    Bull Mem Soc Med Hop Paris; 1967 Feb; 119(4):403-12. PubMed ID: 5596409
    [No Abstract]   [Full Text] [Related]  

  • 20. Pellagra and the carcinoid syndrome.
    Castiello RJ; Lynch PJ
    Arch Dermatol; 1972 Apr; 105(4):574-7. PubMed ID: 4259595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.